HIMS Going up as upcoming earnings are projected to be good with new products (related to TRT and menopause) and expansion in EU and Canada. Also chances of a lawsuit from NVO are looking unlikely. A lawsuit can bring this stock back to $30, otherwise this is going to $75+ next week and $100+ in a few months.
HIMS I haven't been keeping the best eye on Hims as of late after the initial lawsuit filings came into play. Was there any good news that came out as of recent that I missed? could this be tied to the GLP-1 news?